Join
Live feed
·
INSIDERFilingvia Quantisnow
eXoZymes Inc. logo

Vice President, Development Opgenorth Paul Hideo was granted 2,990 shares, increasing direct ownership by 0.47% to 641,150 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
EXOZ· eXoZymes Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EXOZ (eXoZymes Inc.) and more on Quantisnow.